Gilead Sciences stock after-hours at EUR 127.65: minus 0.89 percent
Published on 10/06/2026 at 21:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gilead Sciences stock was at EUR 127.65 in after-hours trading at 9:01 p.m. CEST on October 6, 2026. That was minus 0.89 percent versus the prior close of EUR 128.79 at Lang & Schwarz.
Gilead shares remain in focus after October 6 trading
The October 6 price and the prior close provide the latest dated reference for the stock. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Gilead Sciences stock.
Technology and oncology collaborations extended
Cognizant announced on October 6 a five-year extension of its work with Gilead Sciences. Under the agreement, Cognizant will support Gilead's DevOps capabilities and the responsible application of agentic AI tools across selected technology programs. Gilead Global CIO Anna Berg Asberg said the agreement would provide additional support as the company strengthens its DevOps capabilities and evaluates practical uses of AI.
Separately, Nurix Therapeutics said on October 5 that Nurix and Gilead had agreed to extend the research term for an undisclosed oncology program by two years. The extension is the second two-year extension for that program. Nurix said it would receive a $10 million research term extension fee under the amended collaboration agreement.
